Home » Topics » BioWorld Science

BioWorld Science
RSS

New CDK9/cyclin T1 inhibitors identified at Algen Biotechnologies

Dec. 9, 2021

Shanghai Meiyue Biotech Development describes new coagulation factor XIa inhibitors

Dec. 9, 2021

New model for studying early embryonic development

Dec. 9, 2021

Attenuated T. gondii injection synergizes with PD-L1 checkpoint blockade against mouse tumors

Dec. 9, 2021

Proteogenomics approach identifies neoantigens for T-cell immunotherapy in pediatric brain tumors

Dec. 9, 2021

GreenLight and IAVI partner on mRNA vaccine candidate for SARS-CoV-2 Omicron variant

Dec. 7, 2021

Bsense reports preclinical data on BSEN-627 in rat pain model

Dec. 7, 2021

Alpha Cognition reports preclinical data from ALPHA-1062 intranasal TBI program

Dec. 7, 2021

Spago completes regulatory preclinical program with Tumorad

Dec. 7, 2021

Kaleido and Janssen expand Microbiome Metabolic Therapies collaboration

Dec. 7, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...